← Leaderboards
Jiwon Kim
Weill Medical Coll Of Cornell Univ
$4,201,792
Attributed
$4,201,792
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $870.1K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,201,792 · 2
By mechanism
R01$3,354,566 · 1
K23$847,226 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Jonathan W. Weinsaft$12,053,026
- Mario Fl Gaudino$5,803,713
- Pascal Spincemaille$5,415,841
- Nathaniel R Campbell$193,830
- Lisa Qia Rong$953,845
Others in their field
Other Emerging Leaders on “Tissues”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$61,115,130
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,559,980
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$33,867,067
Research focus
TissuesStemIndexingTechnologyResponseRisk StratificationEchocardiographyImageStructureMyocardial TissuePropertyResolutionRight Ventricular DysfunctionCardiac3-DimensionalCardiopulmonaryFunctional DisorderHeart FailureMyocardiumLeftMagnetic ResonanceMortality RiskAffectVentricular
Grant awards (10)
Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors$701,089
R01 · FY2025 · HL · contact PI
Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors$625,046
R01 · FY2024 · HL · contact PI
Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors$640,107
R01 · FY2023 · HL · contact PI
Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors$687,508
R01 · FY2022 · HL · contact PI
Advanced CMR Tissue-Based Prediction of Right Ventricular Dysfunction and Revascularization Response$169,198
K23 · FY2022 · HL · contact PI
Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors$700,816
R01 · FY2021 · HL · contact PI
Advanced CMR Tissue-Based Prediction of Right Ventricular Dysfunction and Revascularization Response$169,288
K23 · FY2021 · HL · contact PI
Advanced CMR Tissue-Based Prediction of Right Ventricular Dysfunction and Revascularization Response$169,260
K23 · FY2020 · HL · contact PI
Advanced CMR Tissue-Based Prediction of Right Ventricular Dysfunction and Revascularization Response$169,740
K23 · FY2019 · HL · contact PI
Advanced CMR Tissue-Based Prediction of Right Ventricular Dysfunction and Revascularization Response$169,740
K23 · FY2018 · HL · contact PI